Latest news

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Piper Sandler analyst David Westenberg initiates coverage on NeoGenomics (NASDAQ:NEO) with a Overweight rating and announces Price Target of $13.

  On Friday, 1043 companies hit new 52-week lows.

Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  NeoGenomics (NASDAQ:NEO) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.23) by 73.91 percent. This is a 900 percent decrease over losses of $(0.04) per share from the

  Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Raymond James analyst Andrew Cooper maintains NeoGenomics (NASDAQ:NEO) with a Outperform and lowers the price target from $24 to $18.